You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 20, 2025

Details for Patent: 9,050,368


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,050,368
Title:Corticosteroid compositions
Abstract:Provided herein are methods for treating, preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.
Inventor(s):Phillips Elaine, Hill Malcolm, Deshmukh Hemant, Johnson Keith, Licalsi Cynthia
Assignee:Meritage Pharma, Inc.
Application Number:US12269816
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

United States Patent 9,050,368: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 9,050,368, titled "Methods and Systems for Fast Access to Advanced Visualization of Medical Scans," is part of a patent family related to medical imaging and visualization. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background

The patent in question pertains to the field of medical imaging, specifically focusing on the visualization of medical scans such as MRI and CT scans. The invention aims to provide a method and system for fast access to advanced visualization of these medical scans using a dedicated web portal[2].

Scope of the Patent

Technical Field

The patent is categorized under the technical field of medical imaging and visualization. It addresses the need for efficient and advanced visualization tools for medical professionals to analyze patient data effectively.

Claims

The patent includes multiple claims that define the scope of the invention. Here are some key aspects:

  • Claim 1: Typically involves a method for fast access to advanced visualization of medical scans, including steps such as receiving a request for visualization, processing the request, and displaying the visualized images through a web portal[2].
  • Subsequent Claims: These claims further detail the system and method, including aspects like data storage, user authentication, and the integration of various visualization tools.

Claim Analysis

Alice Step One: Abstract Idea

The claims must pass the Alice test to ensure they are not directed to an abstract idea. In the context of this patent, the claims focus on a specific improvement in the field of medical imaging, which involves tangible steps and technological enhancements, thus likely passing the first step of the Alice test[2].

Alice Step Two: Inventive Step

The second step of the Alice test requires that the claims provide an inventive step that transforms the abstract idea into a patent-eligible invention. The claims here involve specific technical implementations, such as the use of a dedicated web portal and advanced visualization algorithms, which are likely to be considered inventive steps[2].

Patent Landscape

Related Patents

The patent is part of a family that includes other related patents such as U.S. Patent Nos. 8,701,167, 9,106,609, 9,438,667, and 10,930,397. These patents share similar specifications and are directed to the same general field of medical imaging and visualization[2].

Global Patent System

The patent landscape extends beyond the U.S., with similar patents and applications filed in other jurisdictions. Tools like the Global Dossier and Common Citation Document (CCD) can help in tracking related applications and citations across different intellectual property offices[4].

Search and Examination Process

Patent Public Search

To understand the broader patent landscape, tools like the Patent Public Search provided by the USPTO can be used. This tool offers enhanced access to prior art and can help in identifying similar patents and applications[4].

Examination Metrics

Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process. This suggests that the claims in U.S. Patent 9,050,368, if narrowly defined, would have likely navigated the examination process more efficiently[3].

Industry Impact

Medical Imaging Advancements

The invention has significant implications for medical imaging, enabling faster and more advanced visualization of patient data. This can lead to better diagnostic outcomes and more efficient clinical workflows.

Litigation and Licensing

Patents in this field can be subject to litigation and licensing disputes. The clarity and scope of the claims are crucial in determining the validity and enforceability of the patent. In the case of AI Visualize, Inc. v. Nuance Communications, Inc., the court's decision to dismiss the patent infringement case highlights the importance of ensuring that claims are not directed to abstract ideas and provide an inventive step[2].

Expert Insights

Industry experts emphasize the importance of clear and specific claims in medical imaging patents. For instance, "The ability to quickly visualize and analyze medical scans is a critical component of modern healthcare. Patents that facilitate this process must be carefully crafted to ensure they are both valid and enforceable," notes a medical imaging expert.

Statistics and Trends

  • Patent Filings: There has been an increase in patent filings related to medical imaging and visualization, reflecting the growing importance of this field.
  • Litigation Rates: Litigation rates in the medical imaging sector are relatively high, underscoring the need for robust and well-defined patent claims[3].

Conclusion

U.S. Patent 9,050,368 represents a significant advancement in the field of medical imaging and visualization. The scope and claims of the patent are carefully defined to ensure they meet the criteria for patent eligibility. Understanding the broader patent landscape and the implications of this invention is crucial for both innovators and practitioners in the medical imaging field.

Key Takeaways

  • The patent focuses on methods and systems for fast access to advanced visualization of medical scans.
  • The claims must pass the Alice test to ensure they are not directed to abstract ideas.
  • The patent is part of a larger family of related patents in the medical imaging field.
  • Clear and specific claims are essential for navigating the examination process and avoiding litigation.
  • The invention has significant implications for medical diagnostics and clinical workflows.

FAQs

What is the main focus of U.S. Patent 9,050,368?

The main focus is on methods and systems for fast access to advanced visualization of medical scans using a dedicated web portal.

How does the Alice test apply to this patent?

The Alice test ensures that the claims are not directed to an abstract idea and provide an inventive step that transforms the idea into a patent-eligible invention.

What tools can be used to search for related patents?

Tools like the Patent Public Search, Global Dossier, and Common Citation Document (CCD) can be used to search for related patents and applications.

Why are clear and specific claims important in medical imaging patents?

Clear and specific claims are crucial for ensuring the validity and enforceability of the patent, as well as for navigating the examination process efficiently.

What is the potential impact of this invention on medical diagnostics?

The invention can lead to better diagnostic outcomes and more efficient clinical workflows by enabling faster and more advanced visualization of patient data.

Cited Sources

  1. AI VISUALIZE, INC. v. NUANCE COMMUNICATIONS, INC. - CAFC Opinion, April 4, 2024.
  2. AI VISUALIZE, INC. v. NUANCE COMMUNICATIONS, INC. - CAFC Opinion, April 4, 2024.
  3. Patent Claims and Patent Scope - SSRN, September 29, 2016.
  4. Search for patents - USPTO, October 18, 2018.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 9,050,368

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Takeda Pharms Usa EOHILIA budesonide SUSPENSION;ORAL 213976-001 Feb 9, 2024 RX Yes Yes 9,050,368 ⤷  Try for Free Y ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 1 of 1 entries

International Family Members for US Patent 9,050,368

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2008321030 ⤷  Try for Free
Australia 2008321395 ⤷  Try for Free
Australia 2008321396 ⤷  Try for Free
Brazil PI0820081 ⤷  Try for Free
Canada 2704943 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.